Meropenem and Ventricular hypokinesia - a phase IV clinical study of FDA data


Ventricular hypokinesia is found among people who take Meropenem, especially for people who are male, 50-59 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Meropenem and have Ventricular hypokinesia. It is created by eHealthMe based on reports of 26,680 people who have side effects when taking Meropenem from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Apr, 01, 2023

26,680 people reported to have side effects when taking Meropenem.
Among them, 15 people (0.06%) have Ventricular hypokinesia.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 26,723 Meropenem users for its effectiveness, alternative drugs and more.

What is Ventricular hypokinesia?

Ventricular hypokinesia (muscle of one's heart does not contract as much as most peoples' hearts do) is found to be associated with 1,191 drugs and 655 conditions by eHealthMe.

Number of Meropenem and Ventricular hypokinesia reports submitted per year:

Could Meropenem cause Ventricular hypokinesia?

Time on Meropenem when people have Ventricular hypokinesia *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Ventricular hypokinesia when taking Meropenem *:

  • female: 38.46 %
  • male: 61.54 %

Age of people who have Ventricular hypokinesia when taking Meropenem *:

  • 0-1: 8.33 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 16.67 %
  • 40-49: 0.0 %
  • 50-59: 50.0 %
  • 60+: 25.0 %

Common drugs people take besides Meropenem *:

  1. Linezolid: 4 people, 26.67%
  2. Dantrium: 4 people, 26.67%
  3. Midazolam Hydrochloride: 4 people, 26.67%
  4. Levofloxacin: 4 people, 26.67%
  5. Lidocaine: 3 people, 20.00%
  6. Vancomycin: 3 people, 20.00%
  7. Albuterol: 2 people, 13.33%
  8. Carvedilol: 2 people, 13.33%
  9. Lasix: 2 people, 13.33%
  10. Humira: 2 people, 13.33%

Common side effects people have besides Ventricular hypokinesia *:

  1. Cardiac Arrest: 7 people, 46.67%
  2. Ventricular Extrasystoles (premature cardiac contraction): 7 people, 46.67%
  3. Fever: 7 people, 46.67%
  4. Depressed Level Of Consciousness: 5 people, 33.33%
  5. Ventricular Fibrillation (abnormally irregular heart rhythm): 5 people, 33.33%
  6. Ejection Fraction Decreased (systolic heart failure): 4 people, 26.67%
  7. Electrocardiogram St Segment Depression: 4 people, 26.67%
  8. Pneumonia: 4 people, 26.67%
  9. Liver Disorder (liver diseases): 4 people, 26.67%
  10. Neuroleptic Malignant Syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents): 4 people, 26.67%

Common conditions people have *:

  1. Fever: 4 people, 26.67%
  2. Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 4 people, 26.67%
  3. Prostate Cancer: 1 person, 6.67%
  4. Cardiomyopathy (weakening of the heart muscle): 1 person, 6.67%
  5. Agitation (state of anxiety or nervous excitement): 1 person, 6.67%
  6. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Meropenem and have Ventricular hypokinesia?

Check whether Ventricular hypokinesia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Ventricular hypokinesia and when was it recovered:

Expand to all the drugs that have ingredients of meropenem:

Alternative drugs to, pros and cons of Meropenem:

Common Meropenem side effects:

Browse all side effects of Meropenem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Ventricular hypokinesia treatments and more:

COVID vaccines that are related to Ventricular hypokinesia:

Common drugs associated with Ventricular hypokinesia:

All the drugs that are associated with Ventricular hypokinesia:

Common conditions associated with Ventricular hypokinesia:

All the conditions that are associated with Ventricular hypokinesia:

How the study uses the data?

The study uses data from the FDA. It is based on meropenem (the active ingredients of Meropenem) and Meropenem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: